EDITORIAL SECTION
-
STRATEGY
Smarter Pharma
Quality management systems QMS are the backbone of pharmaceutical manufacturing ensuring safe products
-
RESEARCH DEVELOPMENT
Cytiva Laboratory capsule filters
Our singleuse selfcontained filtration solution
-
CLINICAL TRIALS
Why Clinical Trials Need Digital Endpoints
According Citeline the average success rate for bringing a Phase candidate to market has dropped to an alltime low of just
-
MANUFACTURING
Ensuring Quality and Compliance in Biopharma
Ensuring quality and regulatory compliance in the biopharmaceutical industry is critical to safeguarding product safety and efficacy
-
Information Technology
The Cost of Bad Data
Modern pharmaceutical research generates an unprecedented volume of information Data from genomic sequencing
-
Biopharma
Reimagining Global Biomanufacturing Capacity with Continuous and Modular Systems
Biotechnology is fueling the ongoing expansion of the global market for a broad array of goods
-
EXPERT Talk
From Compliance to Competitive Advantage
Compliance gets you through an audit Resilience gets medicines to patients on the day something unexpected happens The DSCSAs enhanced requirements took effect November but real interoperability required three more rounds of accommodation phased implementation with the smalldispenser
Advisory Board
KNOWLEDGE BANK
-
Articles
Spleen Cytokines Against Inflammatory Bowel Disease
Over one hundred years ago at the University of Toronto Frederick Banting Charles Best and James Collip extracted protein insulin from the pancreas that saved the lives of millions of diabetics since then It is possible that the proteins extracted from the spleen can also help people with inflammatory bowel disease IBD
Top 5 Pharma Content Formats That Drive Engagement and Leads
The pharmaceutical business is experiencing a significant change in the way it informs the healthcare professionals decisionmakers and business partners Conventional means of promotion is no longer sufficient in a context whereby buyers do a lot of research before involving themselves with vendors Consequently pharma content marketing has turned out to be a vital instrument of establishing credibi...
Pharma Email Marketing Europe: Personalized Campaigns for C-Suite Leads
The pharmaceutical industry is a very competitive industry and to reach the decisionmakers a focused and strategic marketing strategy is necessary Conventional marketing is not often precise enough to reach executives that drive buying alliances and strategic relationships Here the pharma email marketing has come to play as a potent instrument of relationship establishment with the key stakeholder...
Therapeutic Intervention of Polymeric Nanoparticles Combining Bone Marrow Stem Cells for the treatment of Alzheimer’s disease
Alzheimers disease ADis a neurological disorder that is responsible for brain atrophy and neuronal degeneration resulting in a decline in thinking ability and behaviour The progressive neurodegeneration leads to memory loss or dementia which makes it difficult to carry out daytoday tasks and it also has an impact on the socializing ability of the individual
Genetic Testing in Mainstream Medicine: Driving Precision, Prevention, and Population Health
Healthcare systems globally are shifting toward valuebased care where reimbursement is tied to outcomes not procedures Genetic testingparticularly multigene panels and polygenic risk scores is emerging as a highimpact enabler of early intervention and targeted prevention reducing longterm costs and improving clinical outcomes
The Role of Automation in Pharmaceutical Manufacturing
Modern pharmaceutics gained momentum through technological progress which primarily involved automation in pharmaceutical production processes The drug development process now produces major changes in drug manufacturing pipeline operations from start to finish delivery to marketplaces The pharmaceutical industry requires better efficiency together with precision and speed and therefore automation...
-
Techno Trends
FDA Grants Breakthrough Therapy Designation to Calico's Fosigotifator
Calico Life Sciences LLC has announced that the US Food and Drug Administration FDA has granted Breakthrough Therapy Designation to fosigotifator for the treatment of Vanishing White Matter disease a rare and progressive neurological disorder with no approved therapies
-
Projects
Johnson & Johnson Invests $1B to Expand U.S. Vision Manufacturing & Distribution
Johnson Johnson has announced an investment of more than billion to expand its Vision manufacturing operations in Jacksonville Florida The project is designed to increase domestic manufacturing packaging and distribution capacity for the company
-
Research Insights
A genomic-led strategy to anticipate drug safety effects
Safetyrelated issues account for approximately of failures in new drug discovery programs On top of that many are discovered during postmarketing surveillance
-
whitepaper
Placing the Right Bets: Defining Tailored Investment Strategies for Pharma Launch
Pharmaceutical launches have become significantly harder to execute successfully As IQVIAs new white paper highlights median six month cumulative sales for innovative launches have declined by compared with pre levels reflecting shrinking market opportunities
TOP ARTICLES
-
1
Top 5 Pharma Content Formats That Drive Engagement and Leads
Kate Williamson
Strategic content is becoming more popular among pharmaceutical companies as a tool to meet the need of healthcare professionals and produce qualified leads. This paper discusses the top five pharma c...
-
2
Pharma Email Marketing Europe: Personalized Campaigns for C-Suite Leads
Kate Williamson
Pharma email marketing allows pharmaceutical firms to engage high-value decision makers in Europe with personalized and data-based campaigns. When using the mix of targeted outreach, account-based mar...
-
3
Therapeutic Intervention of Polymeric Nanoparticles Combining Bone Marrow Stem Cells for the treatment of Alzheimer’s disease
Ruchi Chawla
Varsha Rani
Mohini Misra
Krishan Kumar
Dementia is the first sign of neuronal impairment related to Alzheimer’s disease (AD). The neurodegeneration initially appears in the hippocampus and cortex which comprises memory developing are...
-
4
Genetic Testing in Mainstream Medicine: Driving Precision, Prevention, and Population Health
Chandni Mansoori
Beyond rare disease diagnosis, the genetic testing is becoming a critical decision-making tool in the mainstream of medicine. This article will explore new opportunities to understand how genomic data...
-
5
The Role of Automation in Pharmaceutical Manufacturing
Kate Williamson
Pharmaceutical product manufacturing executives experience a revolutionary change through automated systems which create increased operational precision along with better control measures. The future...
press releases Read more...
Relation Announces Expanded Collaboration with GSK
Relation today announced a strategic research collaboration with GSK focused on generating largescale human cellular perturbation data and deploying them into models including MORGAN
Resilience and Lilly Invest $750 Million to Increase U.S.-Manufactured Medicine Supply
Resilience a technologyforward contract development and manufacturing organization dedicated to broadening access to complex medicines today announced it has expanded its strategic partnership with Eli Lilly and Company
MiRecule Announces Strategic Collaboration with EMS Group Company Rio Biopharma to Advance Targeted Delivery of RNA Therapeutics
MiRecule Inc a biotechnology company developing nextgeneration RNA therapeutics for rare genetic diseases today announced a strategic research collaboration with Rio Biofarma Brasil Ltda RBBL
Johnson & Johnson Announces Collaboration with Sail Biomedicines to Advance in vivo CAR-T Programs and Transform Autoimmune Disease Through Immune Reset
Johnson Johnson NYSE JNJ today announced strategic agreements and collaboration with Sail Biomedicines Sail a biotechnology company developing in vivo CART therapies for immunemediated diseases
Events Read more...
03 - 04
Aug 2026Clinical Pharmacology and Toxicology 2026
Dubai, UAE
11 - 12
Aug 2026Medical Device Safety Monitoring and Reporting
San Diego, CA, USA
19 - 21
Aug 2026ISPE Conference & Exhibition 2026
Suntec Singapore
20 - 21
Aug 2026Pharmaceutical Formulations 2026
London, UK
20 - 21
Aug 2026Novel Drug Delivery Systems 2026
London, UK
20 - 21
Aug 2026Advanced Clinical Research 2026
London, UK
25 - 27
Aug 2026CPHI Korea 2026
COEX, Seoul, Korea
26 - 27
Aug 2026BIOMEDevice 2026
Boston Convention & Exhibition...
LATEST NEWS Read more...
Abivax Advances NDA Plans for Obefazimod Following Positive FDA Meeting
Abivax has completed a positive preNew Drug Application NDA meeting with the US Food and Drug Administration FDA for obefazimod its investigational treatment for adults with moderately to severely active ulcerative colitis UC
Iksuda Receives FDA Clearance to Begin Phase I Trial of IKS04
Iksuda Therapeutics has received Investigational New Drug IND clearance from the US Food and Drug Administration FDA for IKS allowing the company to begin a Phase I clinical trial in patients with gastrointestinal GI cancers
FDA Grants Orphan Drug Designation to Enzomenib for Acute Lymphoblastic Leukaemia
Sumitomo Pharma America has announced that the US Food and Drug Administration FDA has granted Orphan Drug Designation to enzomenib DSP for the treatment of patients with acute lymphoblastic leukaemia ALL
Allogene Therapeutics Gains FDA RMAT and Fast Track Status for Cema-Cel in First-Line Large B-Cell Lymphoma
Allogene Therapeutics has received Regenerative Medicine Advanced Therapy RMAT and Fast Track designations from the US Food and Drug Administration FDA for its investigational allogeneic CAR T therapy
Ocugen Receives FDA RMAT Designation for OCU410 in Geographic Atrophy
Ocugen has received Regenerative Medicine Advanced Therapy RMAT designation from the US Food and Drug Administration FDA for its investigational gene therapy OCU for the treatment of geographic atrophy
Eton Pharmaceuticals Seeks FDA Approval to Expand KHINDIVI Use in Younger Children
Eton Pharmaceuticals has submitted a Prior Approval Supplement PAS to the US Food and Drug Administration FDA seeking to expand the approved use of KHINDIVI hydrocortisone oral solution




